Concepedia

Ilaria Depetris

ID

10

Publications

1.4K

Citations

10

H-Index

2016

Active since

Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico(Current)

Candiolo Cancer Institute

University of Turin

Istituto Oncologico Veneto

University of Modena and Reggio Emilia

Ilaria Depetris is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in colorectal cancer, medicine, and oncology.

ORCID

Top concepts

Publications per year

2016–2023

10

Publications

10

Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial

Andrea Sartore‐Bianchi, Livio Trusolino, Cosimo Martino et al. · The Lancet Oncology · 2016 · 984 citations · Full text

, , +5

Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

Fotios Loupakis, Ilaria Depetris, Paola Biason et al. · The Oncologist · 2020 · 107 citations · Full text

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

Joris van de Haar, Xuhui Ma, Salo Ooft et al. · Nature Medicine · 2023 · 74 citations · Full text

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study

Fotios Loupakis, Rossana Intini, Chiara Cremolini et al. · European Journal of Cancer · 2019 · 69 citations · Full text

, , +7

The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer

Massimiliano Salati, Roberto Filippi, Caterina Vivaldi et al. · Liver International · 2019 · 57 citations · Full text

Rows per page

1–5 of 10